Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV infections.
Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical ...
SHELTON, CT / ACCESS Newswire / April 21, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
14d
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
The U.S. Food and Drug Administration has granted Priority Review for Aicuris’ New Drug Application for pritelivir, a novel helicase primase ...
Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.
SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...
ANSWER: Your protein intake should be appropriate for your body size. If you weigh 60 kilograms (132 pounds), then 60-70 ...
The Hearty Soul on MSN
Surprising new research reveals what's really raising your dementia risk
Most people picture dementia as something that creeps up in old age, something that belongs to a distant future most of us ...
Have you ever heard of a fully vaccinated 79-year-old woman getting a repeat case of shingles? This is actually my fourth ...
7d
Dear Doctor: I am fully vaccinated against shingles, so why did I just get it for the fourth time?
ANSWER: Chicken pox is a viral illness that is caused by one of the viruses in the herpes family. Shingles is a reactivation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results